Documents posted here were prepared for national regulatory authorities, regional pharmaceutical advisors, regulatory networks and associated stakeholders to provide timely information around development and regulatory approval of COVID-19 related diagnostics, treatments and vaccines.
It is important to highlight that the situation and context have been rapidly evolving so information in previous updates may now be outdated.
Please note that it may not be reviewed, abstracted, quoted, reproduced, transmitted, distributed, translated or adapted, in part or in whole, in any form or by any means without the permission of the World Health Organization.
Regulatory updates
All →Annexes to Regulatory Update
The vaccine pillar, COVAX, of the ACT accelerator has established a Regulatory Advisory Group (RAG) which is co-led by WHO and CEPI. The RAG has members...
The vaccine pillar, COVAX, of the ACT accelerator has established a Regulatory Advisory Group (RAG) which is co-led by WHO and CEPI. The RAG has members...
The vaccine pillar, COVAX, of the ACT accelerator has established a Regulatory Advisory Group (RAG) which is co-lead by WHO and CEPI. The RAG has members...